Most active investors · Last 30 days
Ranked by rounds participated in, from announcements in Sep 24, 2026 – Oct 23, 2026. Lead counts include only confirmed lead roles.
Browse by month
Details
Details
Details
New companies 2 · Follow-on 0
Stages: Seed 2
AIsa Undisclosed Seed extensionEFY Finance Undisclosed SeedDetails
New companies 1 · Follow-on 1
Stages: Series A 1, Series B 1
Sunbound $24M Series AOutmarket AI $34.5M Series BDetails
Details
Details
New companies 2 · Follow-on 0
Stages: Undisclosed 2
N.D.Promotion Undisclosed Strategic investmentContents X Undisclosed Strategic equity investmentDetails
Details
New companies 2 · Follow-on 0
Stages: Series C+ 1, Undisclosed 1
Scimplify $25M Strategic financingNat Habit ₹1.4B Series CDetails
New companies 2 · Follow-on 0
Stages: Seed 1, Undisclosed 1
Stride £4.6M Seed fundingCotierra €2.6M Funding roundDetails
New companies 2 · Follow-on 0
Stages: Undisclosed 2
seragy €12M Mixed financingEverphone €15M €15 million corporate loan refinancingDetails
New companies 2 · Follow-on 0
Stages: Pre-seed 1, Series A 1
Duvo $32M Series AMinerva Humanoids Undisclosed Pre-SeedDetails
Details
New companies 2 · Follow-on 0
Stages: Series A 2
Spill Games $10.5M Series AMesa School of Business ₹1.1B Series A and venture debtDetails
Details
Details
New companies 2 · Follow-on 0
Stages: Series A 1, Series B 1
Salience Labs $125M Series BPicoJool $27.5M Series ADetails
Details
New companies 2 · Follow-on 0
Stages: Pre-seed 1, Undisclosed 1
RocketPay ₹100M UndisclosedZinara ₹36.1M Pre-seedDetails
New companies 1 · Follow-on 1
Stages: Series B 1, Series C+ 1
Modal Labs $750M Series DArmadin $255.5M Series BDetails
New companies 2 · Follow-on 0
Stages: Series A 2
AZOO Undisclosed Series ABridgeSmile Co., Ltd. ¥819M Series ADetails
New companies 2 · Follow-on 0
Stages: Seed 1, Series B 1
Parallel Loop $6.6M SeedHadrian $40M Series BDetails
New companies 2 · Follow-on 0
Stages: Seed 1, Undisclosed 1
OlsAro €5M SeedCotierra €2.6M Funding roundDetails
Details
Details
New companies 2 · Follow-on 0
Stages: Series B 1, Series C+ 1
Soufflé Therapeutics $135M Series BBigHat Biosciences $75M Series CDetails
New companies 2 · Follow-on 0
Stages: Series A 1, Series B 1
Epyr €15M Series AReverion $175M Series BDetails
Details
“—” in Led means every role for that investor in this period is undisclosed; it does not mean zero leads. New companies counts the first participation in a company in our records; follow-on counts later participation.